146项公开的癫痫临床试验正在进行中

“癫痫研究联合公民(CURE)”发布报告称，截至2013年3月4日，在146项公开进行的癫痫临床试验中，近40%为Ⅲ期试验。

根据CURE在clinicaltrials.gov中的搜索，大约有28%的癫痫试验为Ⅱ期，略多于21%为Ⅳ期，近11%为Ⅰ期。

与此同时，目前有85项自闭症临床试验、176项帕金森病临床试验和196项阿尔茨海默病临床试验。

癫痫研究相关出版物的数量从2008年的5313份增至2012年的6049份，增长了14%。相比之下，同期自闭症研究相关出版物增加了78%，帕金森病增加36%，阿尔茨海默病增加37%。

爱思唯尔版权所有  未经授权请勿转载


By: RICHARD FRANKI, Clinical Neurology News Digital Network

Almost 40% of the 146 open epilepsy clinical trials were at phase III as of March 4, 2013, Citizens United for Research in Epilepsy reported.

About 28% of epilepsy trials were at phase II, just over 21% were at phase IV, and almost 11% were at phase I, according to CURE’s search of clinicaltrials.gov.

Compared with the 146 epilepsy trials on that date, there were 85 autism trials, 176 Parkinson’s disease trials, and 196 Alzheimer’s disease trials, the report noted.

The number of research-related publications for epilepsy rose from 5,313 in 2008 to 6,049 in 2012 – an increase of 14%. In comparison, publications increased by 78% for autism, 36% for Parkinson’s, and 37% for Alzheimer’s in that time period, CURE said.

---------------------------------------------------------------------------------------------------------------------------------------------
欢迎关注Elseviermed官方微信